These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7737230)

  • 1. Improvement of the diuretic effect of triamterene via solid dispersion technique with PEG 4000.
    Arias MJ; Gines JM; Moyano JR; Perez-Barrales MJ; Vela MT; Rabasco AM
    Eur J Drug Metab Pharmacokinet; 1994; 19(4):295-302. PubMed ID: 7737230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of solid dispersion technique with D-mannitol to the improvement in oral absorption of triamterene.
    Arias MJ; Gines JM; Moyano JR; Rabasco AM
    J Drug Target; 1994; 2(1):45-51. PubMed ID: 8069583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution properties and in vivo behaviour of triamterene in solid dispersions with polyethylene glycols.
    Arias MJ; Ginés JM; Moyano JR; Rabasco AM
    Pharm Acta Helv; 1996 Oct; 71(4):229-35. PubMed ID: 8921741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000.
    Asyarie S; Rachmawati H
    PDA J Pharm Sci Technol; 2007; 61(5):400-10. PubMed ID: 18047178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
    Dhumal RS; Biradar SV; Aher S; Paradkar AR
    J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical stability of solid dispersions containing triamterene or temazepam in polyethylene glycols.
    Dordunoo SK; Ford JL; Rubinstein MH
    J Pharm Pharmacol; 1997 Apr; 49(4):390-6. PubMed ID: 9232536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution and bioavailability enhancement of alpha-asarone by solid dispersions via oral administration.
    Deng L; Wang Y; Gong T; Sun X; Zhang ZR
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1817-1826. PubMed ID: 28665158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The delivery of triamterene by cucurbit[7]uril: synthesis, structures and pharmacokinetics study.
    Ma WJ; Chen JM; Jiang L; Yao J; Lu TB
    Mol Pharm; 2013 Dec; 10(12):4698-705. PubMed ID: 24188081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization and in vivo properties of Zolpidem in solid dispersions with polyethylene glycol 4000 and 6000.
    Trapani G; Franco M; Latrofa A; Pantaleo MR; Provenzano MR; Sanna E; Maciocco E; Liso G
    Int J Pharm; 1999 Jul; 184(1):121-30. PubMed ID: 10425358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of binary and ternary solid dispersions on the in vitro dissolution and in-situ rabbit intestinal absorption of gliclazide.
    El-Maghraby GM; Alomrani AH
    Pak J Pharm Sci; 2011 Oct; 24(4):459-68. PubMed ID: 21959805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
    Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
    Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies with triamterene derivatives for oral application.
    Priewer H; Kraft H; Mutschler E
    Arzneimittelforschung; 1985; 35(12):1819-21. PubMed ID: 4096735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
    Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
    Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
    Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
    Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
    Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
    Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions.
    Zerrouk N; Chemtob C; Arnaud P; Toscani S; Dugue J
    Int J Pharm; 2001 Aug; 225(1-2):49-62. PubMed ID: 11489554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.